Purchase Order 75N91024P00321
Award Date 3/15/24
Potential Completion Date 7/1/24
Potential Value $11K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute awarded a purchase order to Akoya Biosciences, Inc. for $13,400.00 on January 25, 2018, with completion targeted for February 25, 2018. The order is firm fixed price with no set-aside. Akoya is a small disadvantaged business specializing in spatial phenotyping and advanced tissue imaging solutions. Place of performance is Bethesda, Maryland. The specific scope of this order is not detailed in the source material.</p>
- This is a firm fixed-price purchase order awarded by the National Cancer Institute to Akoya Biosciences, Inc. (doing business as Phenoptics), a self-certified small disadvantaged business manufacturer of goods, for a service contract to provide a PhenoCycler instrument. The total ceiling value of the contract is $10,020.00, and the ultimate completion date is July 30, 2025. The award is not associated with a set-aside program. Akoya Biosciences is a biotechnology company that specializes in...
- The National Cancer Institute awarded a purchase order to Akoya Biosciences, Inc. for $15,300.00 on April 15, 2020, with ultimate completion by April 30, 2021. The order is firm fixed-price with no set-aside used. Work is performed in Bethesda, Maryland. Akoya, a small disadvantaged business and biotechnology company specializing in spatial phenotyping and tissue imaging solutions, supplies specialized imaging systems, reagents, and diagnostic technologies to support federal healthcare and...
- This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) National Cancer Institute to Akoya Biosciences, Inc., a self-certified small disadvantaged business. The contract has a potential value of $16,560.00 and a period of performance through April 30, 2025. Akoya, operating under the trade name Phenoptics, will provide goods and services to support medical imaging, diagnostic testing, and pathology operations. This includes the delivery of OPAL reagent packs,...
- This is a firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Akoya Biosciences, Inc. (doing business as Phenoptics), a for-profit small disadvantaged business. The $16,560 contract is for a maintenance agreement on an Akoya Mantra quantitative imaging system (serial number MN1548N0024) located at the NCI campus in Bethesda, Maryland. The award does not utilize a set-aside and has an ultimate...
- <p>The National Cancer Institute awarded a purchase order to Akoya Biosciences, Inc. for $14,150.00 on January 17, 2019, with a completion date of February 18, 2019. No set-aside was used. Work is performed in San Francisco, California. Akoya is a small disadvantaged business specializing in spatial phenotyping and advanced tissue imaging solutions. The order is firm fixed-price.</p>
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a firm fixed price purchase order to Akoya Biosciences, Inc. doing business as Phenoptics, a self-certified small disadvantaged business, to provide a PHENOCYCLER PM. The contract has a potential value of $9,540.00 with a completion date of March 27, 2025. This award is not set aside for any specific business category. Akoya Biosciences is a biotechnology company that specializes in...
- <p>The National Cancer Institute awarded a purchase order to Akoya Biosciences, Inc. for $14,844.00 on March 27, 2019, with an ultimate completion date of April 30, 2020. Performance occurs in Menlo Park, California. The order is for a service agreement priced on a firm fixed-price basis. Akoya is a small disadvantaged business and manufacturer of advanced tissue imaging and spatial phenotyping solutions.</p>
- This federal contract award is for the procurement of PHENOCYCLER REAGENTS by the National Cancer Institute (NCI), a civilian agency under the U.S. Department of Health and Human Services. The $12,737.00 firm fixed price purchase order was awarded to Akoya Biosciences, Inc., doing business as Phenoptics, a for-profit biotechnology company and manufacturer of goods. This contract is not designated as a small business set-aside. Akoya Biosciences has been awarded numerous federal contracts and...
- This federal contract award was made by the National Institute of Dental and Craniofacial Research (NIDCR), a civilian agency under the National Institutes of Health (NIH), to Akoya Biosciences, Inc., doing business as Phenoptics. The $98,600 firm-fixed-price purchase order is for the delivery of Codex fluidics instrumentation, which are specialized laboratory equipment for medical research applications. The contract has no set-aside designation and was awarded on a competitive, non-set-aside...